Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

NRSNW

NeuroSense Therapeutics Ltd.

CIK 0001875091 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$0.04
↓ 0.01 (-10.80%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 2/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Fundamentals; Risks: Technicals; Excluded: Ownership, Options (no data)

Key stats

Market Cap
$1.45M
P/E Ratio
-0.13
EPS
-0.44
Dividend Yield
Not covered
52W Position
1%
Beta
0.14

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
-0.93
P/S
Not covered
EV/Revenue
Not covered
ROE
713.1%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 1%
$0.04$0.70

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$11.13M
Total Assets
$1.03M
Free Cash Flow
-$7.68M

Recent news